About Spire Labs India Private Limited
Data last updated:
Spire Labs India Private Limited is a private limited company based in Coimbatore, Tamil Nadu, India, a subsidiary of Dr.Ganesan's Hitech Diagnostic Centre Private Limited. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 17 August 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Coimbatore, under CIN U85195TZ2012PTC018650.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Ganesan Manimegalai and Subramanian Ganesan.
Its last annual general meeting (AGM) was held on 29 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at No 20 Tatabad 3rd Street, Coimbatore, Tamil Nadu, India – 641012.
The company has about 5 employees on its provident fund (EPFO) records.
The company has 1 deal on record (1 secondary share transfer); the latest was in March 2014. Its 3 peer companies in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities) are compared by revenue, 2 larger and 1 smaller; the largest is Kripa J.G.J Wellness Private Limited with revenue of ₹1,010.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website spirelabsindia.com.
Company details
Contact details
Spire Labs India Private Limited's registered office is in Coimbatore, Tamil Nadu. Its website is spirelabsindia.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressNo 20 Tatabad 3rd Street, Coimbatore, Tamil Nadu, India – 641012
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Spire Labs India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Spire Labs India Private Limited
FY 2021 filings availableSpire Labs India Private Limited reported revenue of ₹306 (down 100% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 87% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | |||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | |||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Spire Labs India Private Limited, buy the company report.
Board of directors of Spire Labs India Private Limited
Spire Labs India has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ganesan Manimegalai | Director | 06 Feb 2014 | 12 Years 8 Months | Current |
| Subramanian Ganesan | Director | 06 Feb 2014 | 12 Years 8 Months | Current |
Peer comparison
Spire Labs India Private Limited is compared with the 3 companies closest to it by revenue in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Kripa J.G.J Wellness Private Limited | ₹1,010 (FY 2025) | Dehradun, Uttarakhand, India | ||||
| Healthequity Diagnostics Private Limited | ₹450 (FY 2025) | -100.0% | Delhi, India | |||
| Spire Labs India Private Limitedthis company | ₹306 (FY 2021) | -100.0% | 5 | Coimbatore, Tamil Nadu, India | ||
| Sheela Memorial Hospital and Diagnostic Centre Private Limited | ₹154 (FY 2024) | 27.0% | Uttar Pradesh, India |
To see the full peer comparison of Spire Labs India Private Limited, buy the company report.
Auditor
Spire Labs India Private Limited is audited by SRV & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SRV & ASSOCIATES | FY 2017 | 010830S |
Shareholding
The shareholding of Spire Labs India Private Limited is on record for 3 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Spire Labs India Private Limited, buy the company report.
Deals & funding
Spire Labs India Private Limited has 1 deal on record (1 secondary share transfer); the latest was in March 2014.
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2014 | Secondary share transfer | Undisclosed | Buyer: Dr Ganesans Hitech Diagnostic Centre Private Limited, Dr Ganesans Hitech Diagnostic Centre Private Limited & Subramanian Ganesan Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Spire Labs India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Spire Labs India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Spire Labs India Private Limited has a workforce of 5 employees on its EPFO records as of Apr 06, 2024, across 1 active EPFO establishment.
GST
No GST registration is on our record for Spire Labs India Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Spire Labs India Private Limited has 7 board changes on record since 2014: 2 appointments and 5 cessations. The latest: Subramanian Lakshminathan ceased to be Whole-Time Director on 23 Nov 2016.
Frequently asked questions
Spire Labs India is an active private limited company based in Coimbatore, Tamil Nadu, India. The company works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 17 August 2012 (14+ years old) and is registered under CIN U85195TZ2012PTC018650.
Spire Labs India has 2 current directors:
- Ganesan Manimegalai - Director
- Subramanian Ganesan - Director
The latest financial statements of Spire Labs India on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 29 November 2021. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Spire Labs India is U85195TZ2012PTC018650. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Spire Labs India was incorporated on 17 August 2012, making it 14+ years old. It is registered with the Registrar of Companies, Coimbatore.
Spire Labs India has 1 deal on record (1 secondary share transfer); the latest was in March 2014.
The peers of Spire Labs India by revenue are Kripa J.G.J Wellness Private Limited, Healthequity Diagnostics Private Limited, Sheela Memorial Hospital and Diagnostic Centre Private Limited, all in the Healthcare industry (Diagnostics and Pathology Labs), with the same principal business activity (other hospital and medical care activities).
Subramanian Lakshminathan ceased to be Whole-Time Director on 23 Nov 2016. Ganesan Manimegalai ceased to be Additional Director on 29 Sep 2014. Subramanian Ganesan ceased to be Additional Director on 29 Sep 2014. Spire Labs India has 7 board changes on record in total.
Spire Labs India can be reached through the website spirelabsindia.com. Its registered office is in Coimbatore, Tamil Nadu, India.
The registered office of Spire Labs India is at No 20 Tatabad 3rd Street, Coimbatore, Tamil Nadu, India – 641012.
Spire Labs India operates in the healthcare industry, in the diagnostic centers and pathology labs segment.